Oritavancin for the Treatment of Staphylococcus aureus Bacteremia—A Retrospective Single-arm Cohort Study - Poll - MDSpire

Oritavancin for the Treatment of Staphylococcus aureus Bacteremia—A Retrospective Single-arm Cohort Study

  • By

  • H Jordan

  • K Kozierowski

  • R Pickles

  • J S Davis

  • June 12, 2025

  • 0 min

Share

Original Source(s)

Oritavancin for the Treatment of Staphylococcus aureus Bacteremia—A Retrospective Single-arm Cohort Study

  • by H Jordan, K Kozierowski, R Pickles, J S Davis

  • June 12, 2025

Related Content

Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistant Staphylococcus aureus infection in a patient with type 2 diabetes mellitus

Biogenic Caralluma sinaica-derived silver nanoparticles as a synergistic antibacterial and osteoinductive nanoplatform for osteomyelitis management

Gold Nanostars Take SERS Inside the Biofilm

Steven Bell explains how – and why – he’s tracking antibiotic diffusion in living biofilms